glp 1 agonist new drug Danuglipron: An Oral GLP-1R Competing with Peptide Injectables for Diabetes and Obesity GLP-1 Receptor Agonists: From Diabetes

Diabetes Care 41(10):22292235

Pharmaceutical GLP-1 medications represent genuine scientific breakthroughs, with clinical trial outcomes documenting effectiveness that previous weight loss interventions couldn't match

Taking Aim at the Compounding Market What makes this report particularly fascinating from an industry perspective is WWs willingness to throw a sharp elbow at its digital health competitors.In the report, WW explicitly calls out telehealth giant Hims & Hers

Dipeptidyl peptidase-4 inhibitors and gallbladder or biliary disease in type 2 diabetes: systematic review and pairwise and network meta-analysis of randomised controlled trials

Its part of a group of drugs called GLP-1 receptor agonists